T1	chemical 0 11	Amphetamine
T2	disease_or_phenotypic_feature 30 42	coagulopathy
T3	disease_or_phenotypic_feature 44 56	hyperthermia
T4	disease_or_phenotypic_feature 73 86	renal failure
T5	chemical 90 97	antigen
T6	disease_or_phenotypic_feature 134 144	malignancy
T7	disease_or_phenotypic_feature 153 160	cancers
T8	disease_or_phenotypic_feature 209 214	small
T9	chemical 266 270	drug
T10	chemical 271 286	hematoporphyrin
T11	chemical 299 308	Serotonin
T12	chemical 313 317	drug
T13	disease_or_phenotypic_feature 326 344	movement disorders
T14	disease_or_phenotypic_feature 389 399	ichthyosis
T15	disease_or_phenotypic_feature 401 423	palmoplantar keratosis
T16	disease_or_phenotypic_feature 425 437	hearing loss
T17	disease_or_phenotypic_feature 439 462	intellectual disability
T18	chemical 475 478	hip
T19	disease_or_phenotypic_feature 492 504	microcephaly
T20	disease_or_phenotypic_feature 509 522	short stature
T21	disease_or_phenotypic_feature 635 641	cancer
T22	chemical 642 646	drug
T23	chemical 648 659	doxorubicin
T24	chemical 680 683	dye
T25	chemical 685 702	indocyanine green
T26	chemical 721 728	antigen
T27	disease_or_phenotypic_feature 754 765	lung cancer
T28	chemical 767 774	Alcohol
T29	chemical 794 799	toxin
T30	disease_or_phenotypic_feature 834 847	heart failure
T31	chemical 890 893	RNA
T32	disease_or_phenotypic_feature 905 913	melanoma
T33	disease_or_phenotypic_feature 982 995	hypercalcemia
T34	disease_or_phenotypic_feature 1004 1017	renal failure
T35	chemical 1123 1138	pharmaceuticals
T36	chemical 1140 1149	vitamin D
T37	chemical 1151 1164	retinoic acid
T38	chemical 1187 1193	oxygen
T39	disease_or_phenotypic_feature 1209 1242	sudden sensorineural hearing loss
T40	disease_or_phenotypic_feature 1247 1255	tinnitus
T41	disease_or_phenotypic_feature 1257 1292	Intraoperative floppy iris syndrome
T42	chemical 1298 1302	drug
T43	chemical 1345 1355	tamsulosin
T44	disease_or_phenotypic_feature 1372 1380	cataract
T45	disease_or_phenotypic_feature 1394 1403	hepatitis
T46	chemical 1412 1419	antigen
T47	chemical 1421 1426	HBsAg
T48	chemical 1568 1575	biology
T49	disease_or_phenotypic_feature 1587 1593	cancer
T50	chemical 1594 1598	drug
T51	chemical 1629 1640	antioxidant
T52	chemical 1641 1652	glutathione
T53	disease_or_phenotypic_feature 1672 1685	HIV infection
T54	disease_or_phenotypic_feature 1693 1700	obesity
T55	disease_or_phenotypic_feature 1723 1730	adenoma
T56	chemical 1761 1769	hormones
T57	chemical 1791 1818	adrenocorticotropic hormone
T58	chemical 1849 1853	GHRH
T59	chemical 1854 1865	antagonists
T60	chemical 1874 1882	androgen
T61	disease_or_phenotypic_feature 1895 1911	prostate cancers
T62	chemical 1940 1948	androgen
T63	chemical 1967 1975	androgen
T64	disease_or_phenotypic_feature 2011 2024	hyperglycemia
T65	disease_or_phenotypic_feature 2029 2043	hyperlipidemia
T66	chemical 2124 2131	glucose
T67	chemical 2142 2151	oxidation
T68	chemical 2184 2187	DNA
T69	disease_or_phenotypic_feature 2255 2268	breast cancer
T70	disease_or_phenotypic_feature 2342 2356	hypothyroidism
T71	disease_or_phenotypic_feature 2372 2390	diabetes insipidus
T72	chemical 2392 2406	growth hormone
T73	disease_or_phenotypic_feature 2419 2432	hyperuricemia
T74	disease_or_phenotypic_feature 2437 2451	hyperlipidemia
R1	causes_or_contributes_to Arg1:T1 Arg2:T2	
R2	causes_or_contributes_to Arg1:T1 Arg2:T3	
R3	causes_or_contributes_to Arg1:T1 Arg2:T4	
R4	causes_or_contributes_to Arg1:T12 Arg2:T13	
T75	missed_chemical 524 551	Albumin based nanoparticles
T76	missed_chemical 524 537;553 556	Albumin based NPs
R5	treats Arg1:T25 Arg2:T21	
R6	treats Arg1:T75 Arg2:T21	
R7	treats Arg1:T76 Arg2:T21	
R8	treats Arg1:T23 Arg2:T21	
R9	causes_or_contributes_to Arg1:T28 Arg2:T30	
R10	causes_or_contributes_to Arg1:T36 Arg2:T33	
R11	causes_or_contributes_to Arg1:T37 Arg2:T33	
T77	missed_chemical 1166 1173	lithium
R12	causes_or_contributes_to Arg1:T77 Arg2:T33	
T78	corrected_chemical 1176 1193	Hyperbaric oxygen
R13	treats Arg1:T78 Arg2:T40	
R14	treats Arg1:T78 Arg2:T39	
R15	causes_or_contributes_to Arg1:T43 Arg2:T41	
T79	corrected_chemical 1849 1865	GHRH antagonists
T80	corrected_disease_or_phenotypic_feature 1874 1911	androgen-independent prostate cancers
T81	missed_disease_or_phenotypic_feature 1967 1992	androgen-sensitive tumors
R16	treats Arg1:T79 Arg2:T80	
R17	treats Arg1:T79 Arg2:T81	
T82	missed_chemical 2223 2234	palbociclib
T83	missed_chemical 2239 2250	fulvestrant
R18	treats Arg1:T83 Arg2:T69	
R19	treats Arg1:T82 Arg2:T69	
T84	missed_disease_or_phenotypic_feature 1986 1992	tumors
R20	causes_or_contributes_to Arg1:T63 Arg2:T84	
